Month: August 2023

HHS Announces First 10 Drugs Eligible for Medicare Price Negotiations

August 29, 2023 William Newton, Associate Editor/Senior Writer Views

CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.

The Department of Health and Human Services (HHS) today announced the first 10 prescription drugs eligible for Medicare price negotiations [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AstraZeneca Sues to Block Medicare Price Negotiations Over ‘Unintended Consequences’ to Orphan Drug Development

August 29, 2023 William Newton, Associate Editor/Senior Writer Views

AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year but allow 340B covered entities to replenish their supply with an equivalent dose in blister pack package form.

Drugmaker AstraZeneca sued the federal government to block Medicare drug price negotiations on Friday, just days before the government announced [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Center Leaders Urge Boards to Push State, Federal Support of 340B

August 29, 2023 Rich Daly, Editor in Chief Views

The National Association of Community Health Centers’ CHI and Expo addressed the advocacy role of health center boards of directors.

The boards of directors of health centers need to take on a bigger advocacy role in support of the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B INDUSTRY LEADER SPOTLIGHT

Liz Trenkel, Senior Compliance Specialist, RPh Innovations

August 29, 2023 Diane Slafsky Views

Q: Where did you grow up?

In the small town of Vale, Oregon. I now live outside of Chicago, Illinois.

Q: Where did you go to college?

I graduated from the College of Idaho with a Bachelor of Science.

Q: What are your favorites?

Food: Sushi

Movie: Pride and Prejudice

Musicians: Maren Morris, Halsey

Destination: Venice,

…

Health Center Asks Court to Reject Drug Maker Briefs in Challenge to 340B Patient Definition

August 24, 2023 William Newton, Associate Editor/Senior Writer Views

Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.

A health center challenging the government’s 340B program patient definition in a federal district court recently asked a federal judge [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHA Urges Dropping Bill Language to Exclude Generic Injectables from 340B

August 24, 2023 Rich Daly, Editor in Chief Views

AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

The nation’s largest hospital advocacy organization urged legislators to drop a provision from draft legislation that would exclude generic injectables [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Provider-PhRMA Coalition Adds Civil Rights Group

August 24, 2023 Rich Daly, Editor in Chief Views

ASAP 340B, a coalition of a drug industry trade group and a community health center organization, added a civil rights group to its membership.

An alliance led by a powerful drug industry trade group and community health center organization that is pushing for 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

From the Publisher & CEO: The Big Question on the Minds of Every 340B Stakeholder

August 24, 2023 Rich Daly, Editor in Chief Views

340B stakeholders are anticipating two major contract pharmacy judicial rulings, including one from the Court of Appeals for the District of Columbia.

Amid nationwide uncertainty over both the legality of the scope of the 340B contract pharmacy program and the legality of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Appeals Court Schedules Arguments in Challenge to Arkansas Contract Pharmacy Law

August 22, 2023 William Newton, Associate Editor/Senior Writer Views

Two states have laws protecting 340B contract pharmacy arrangements and two others have passed 340B reporting requirements.

A federal appeals court has scheduled oral arguments for September in a case challenging Arkansas’ protections for 340B providers’ contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Maker Owes 340B Providers Repayment, HRSA Pending Audit Finds

August 22, 2023 Rich Daly, Editor in Chief Views

A HRSA fiscal year 2023 audit tentatively found that drug maker Nephron Pharmaceuticals owes 340B repayments to providers.

The first posted fiscal year 2023 audit of a drug maker tentatively found the company owes repayments to providers. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B INDUSTRY LEADER SPOTLIGHT

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live